HAPTEN-SPECIFIC IgE ANTIBODY RESPONSES IN MICE : I. SECONDARY IgE RESPONSES IN IRRADIATED RECIPIENTS OF SYNGENEIC PRIMED SPLEEN CELLS by Hamaoka, Toshiyuki et al.
HAPTEN-SPECIFIC  IgE  ANTIBODY  RESPONSES  IN  MICE 
I.  SECONDAR'x  r IgE  RESPONSES IN  IRRADIATED RECIPIENTS OF 
SYNGENEIC PRIMED SPLEEN CELLS* 
By TOSHIYUKI HAMAOKA, DAVID H.  KATZ, KURT J.  BLOCH, AND 
BARUJ BENACERRAF 
(From  the  Department  of  Pathology  and  Department  of Medicine,  Harvard  Medical 
School, Boston, Massachusetts 02115) 
(Received for publication 16 April  1973) 
The induction of humoral immune responses to a variety of antigens requires 
the  cooperative participation  of both  thymus-derived  (T)  and  bone marrow- 
derived  (B)  lymphocytes. The former cells exert very definite regulatory in- 
fluences  on  the  responses of IgM  and  IgG B  lymphocyte precursors  of anti- 
body-forming cells with  respect to  triggering  and  differentiative events  after 
exposure to antigen  (reviewed in ref. 1). An understanding of T  cell regulation 
of IgE antibody responses, in particular, would be highly desirable because of 
its practical application for the control of many allergic diseases. 
Evidence obtained in recent studies by other investigators (2  6) has strongly 
indicated  the participation of T  cell functions in hapten-specific IgE antibody 
responses in rats and rabbits. Studies of IgE antibody production in mice have 
demonstrated a histocompatibility-linked genetic control over responses of this 
immunoglobulin  class  to  certain  antigens  (7)  which,  by  analogy with  other 
well-defined genetically-controlled specific immune responses (8), also implies a 
necessary role for T  cell participation. However, the nature of T  cell regulation 
of IgE antibody production, if it indeed exists, is largely unknown. Specifically, 
a crucial question concerns whether or not the effect of activated helper T  cells 
on  IgE production  follows  the  same general  pattern,  both  qualitatively  and 
quantitatively  observed in  the  elicitation  of IgG antibody responses  and,  by 
extension,  whether  the same or different T  cells  operate on the two  antibody 
class precursor lymphocytes, respectively. 
In  the  present  report,  we  describe  the  successful  transfer  to  irradiated  re- 
cipients, in several strains of inbred mice, of specific IgE antibody responses to 
the hapten  2,4-dinitrophenyl  (DNP)  conjugated  to different protein carriers, 
using spleen cells from syngeneic donors sensitized  to produce IgE antibodies. 
This system will permit further detailed analysis of the  activities of specific B 
and T lymphocytes, respectively, in  the generation of lgE as compared to IgG 
antibody responses. 
Materials and Methods 
Proteins and  llapten-Protein Conjugates.--KeyhoIe limpet hemocyanin (KLH) was pur- 
chased from Pacific Bio-Marine Supply Co., Venice, Calif. Ascaris proteins (ASC) were ex- 
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tracted from Ascaris suum as described by others (9).  Bovine gamma globulin  (BGG)  was 
obtained from Pentex Biochemical, Kankakee, Ill. The following  DNP conjugates were pre- 
pared as previously described (I0,  11): DNP14-KLH, DNP2.1-ASC,  and DNP~2-BGG.  Sub- 
scripts refer to the number of moles of DNP per  100,000 molecular weight units of KLH; 
per mole of carrier for BGG and moles of DNP  X  10  -7 per milligram of ASC protein. 
Animals.--Mice of the inbred lines A/J, BALB/c, and (A X  BALB/c)F1 hybrids (CAF1) 
were obtained from the Jackson Laboratories, Bar Harbor, Maine. All mice were immunized 
at 8-12 wk of age.  Random-bred white female CFW mice used to assay IgE antibody titers 
were obtained from Carworth Farms, New City, N. Y. 
Immunizations.--Mice  were primarily immunized by  intraperitoneal injection  of  either 
DNP-KLH (2 /~g) or DNP-ASC (1  or 10 #g) mixed with 2  10 mg of AI(OH)~ gel in a  total 
volume of 0.5 ml of saline.  Al(OH)s gel (alum)  was prepared by mixing equal volumes of 2N 
AI2(SO4).~ and 2N NaOH  as described by Levine and Vaz  (7). Mixtures of hapten-protein 
conjugates with alum were prepared immediately before use.  In some experiments the mice 
were secondarily immunized using the  same dose and  route  of administration of antigen- 
alum mixture. Mice were bled from the retro-orbital venous plexus at appropriate intervals 
after primary and/or secondary challenge and serum levels of IgE and IgG anti-DNP anti- 
bodies were determined as described below. 
Adoptive Cell Transfer System.--Mice were primed with either  1-2  #g of DNP-KLH or 
10 #g of DNP-ASC mixed with 2 or 10 mg of alum. In some instances booster injections were 
administered 4 wk after primary immunization. 4 wk after the primary or secondary immun- 
ization, these DNP-primed mice were killed and their spleens removed. Single cell suspensions 
in  Eagle's minimum essential medium  (MEM)  were prepared, washed and  transferred in- 
travenously to syngeneic, irradiated (500 r)  recipients (50  X  l0  G  cells per recipient). Imme- 
diately after cell transfer, secondary challenge was performed intraperitoneally with a DNP- 
protein conjugate mixed with alum. All mice were bled 7 days after cell transfer and challenge 
and serum anti-DNP antibody levels were determined. 
Measuremenl of A nti-DNP A ntibodies.-- 
IgE antibodies:  The level of reaginic (IgE)  anti-DNP antibodies in pools of sera from 
groups of five mice were determined by passive cutaneous anaphylaxis (PCA) reactions using 
shaven CFW test mice as described by Levine and Vaz (7). Briefly, 25/zl aliquots of serum 
from each mouse within a  given group were pooled and serially diluted (twofold)  in saline. 
50 #l of each serum dilution were injected intradermally into the dorsal skin surface of the 
test mice. 48 h after intradermal sensitization, DNP-specific PCA reactions were elicited by 
intravenous injection of 500 #g of DNP-BGG in 0.3 ml of 0.5% Evans blue dye dissolved in 
5% dextrose-water solution. Reactions were read and recorded as the reciprocal of the high- 
est dilution of serum evoking threshold PCA reactivity (5 mm diameter). Sera which failed 
to elicit detectable PCA reactions were arbitrarily assigned a  value of  <5. 
Two points of importance should be emphasized about the IgE assay. Firstly, the PCA 
sensitizing antibody being measured here is labile to heating at 56°C for 2 h, and is optimally 
detected 48 h after intradermal sensitization of the test mice. These are characteristic proper- 
ties of reaginic antibodies of the IgE class and rule out any contribution of skin-sensitizing 
antibodies of the IgG1 antibody class (12). Secondly, the DNP-specificity  of the IgE antibodies 
is verified  by the fact that a DNP-conjugate of an unrelated carrier protein (BGG)  has been 
used to test for such antibodies (under condition where the BGG carrier molecule alone fails 
to  elicit a  positive PCA),  and  moreover, that  the PCA reactions could  be specifically  in- 
hibited with univalent DNP-L-lysine. 
IgG serum antibodies:  Serum IgG  anti-DNP  antibody levels were determined in  indi- 
vidual  sera by  a  modified  Farr  technique  (13) using  [3H]DNP-e-amino-N-caproic acid  as 
previously described (10). 
RESULTS  AND  DISCUSSION 
Elicitation  of  D.VP-Specific  [gE  Antibody  Responses  in  Mice.--Groups  of 
A/J,  BALB/c,  and  CAFt mice were primarily immunized with either  1 or  10 308  1-IAMAOKA ET  AL.  BRIEF  DEFINITIVE REPORT 
~g of DNP-ASC  plus alum  (10 rag)  or 2/~g of DNP-KLH plus alum  (2 rag). 
All animals received a second injection of antigen-alum mixture (same dose) 30 
days after primary immunization. Mice were bled at 10,  20, and 30 days after 
primary immunization,  and again  7 days after the secondary challenge.  The 
levels of IgE antibody production  in  the  three strains  of mice employed are 
depicted graphically in Fig.  1. 
All  strains  tested  made  easily  detectable  DNP-specific  IgE  antibody  re- 
sponses  by  day  10  after  primary  immunization  with  small  doses  of  either 
DNP-ASC or DNP-KLH. Although the magnitude of IgE antibody production 
differed among the strains and with respect to the antigen and dose employed, 
the kinetic patterns of response were strikingly similar. Thus, peak antibody 
production  was  attained  around  20  days  after primary immunization,  after 
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Fie..  1. Elicitation of DNP-specific IgE antibody responses in mice. Groups of five mice 
of the inbred lines A/J, BALB/c, and CAF1 hybrids were immunized intraperitoneally with 
either DNP-ASC or DNP-KLH plus alum in the doses indicated. The mice were bled on 
days 10, 20, and 30 at which time secondary challenge with the same antigen and dose was 
performed. A final bleeding was made 7 days after  secondary challenge. Levels of serum 
IgE anti-DNP  antibody at the various times of bleeding are illustrated. 
which the IgE titers in serum diminished. Although not shown in Fig. 1, other 
experiments in our laboratory on kinetics of the primary response have demon- 
strated that serum IgE titers diminish to undetectable levels by day 40 or 50 
after a  single immunization in all  three of these mouse strains.  On  the other 
hand,  administration  of  a  secondary challenge  on  day 30  elicited  very good 
anamnestic IgE anti-DNP antibody responses in all strains (Fig.  1), provided 
such challenge was made with the original immunizing DNP-conjugate. Chal- 
lenge with an unrelated DNP-carrier conjugate consistently failed to induce a 
secondary IgE anti-DNP response. 
Adoptive  Transfer  of DNP-Specific  IgE  Antibody  Responses With  DNP- 
Primed Spleen Cells.--The capacity to elicit very brisk anamnestic IgE anti- 
DNP antibody responses with the homologous DNP-protein used for priming 
provides a  clear indication  of the development of a  specific IgE memory cell 
pool under  these  conditions  of priming.  This essential  requisite  for adoptive 
immunity experiments having been demonstrated, we were then able to design HAMAOKA  ET  AL,  BRIEF  DEFINITIVE  REPORT  309 
and test experimental conditions capable of allowing successful  adoptive trans- 
fer of the IgE anti-DNP response. 
Several experiments of this type were performed. The protocol and results of 
three such experiments are summarized in Table I.  In the first, spleen cells 
from A/J donor mice that had been primed with DNP-ASC (10/xg) plus 10 mg 
alum were injected intravenously into syngeneic, irradiated recipients.  Two 
types of primed spleen cells were used as indicated in the table. A control group 
of  recipients  were  injected with  spleen  cells  from nonimmunized syngeneic 
donors.  Secondary challenge with  10/zg  of DNP-ASC  plus  1 mg  alum was 
performed immediately after cell  transfer.  Curiously, the best  adoptive sec- 
ondary IgE responses to DNP-ASC were displayed by recipients of cells from 
singularly primed donors; nonetheless, clear adoptive secondary responses were 
elicited in recipients of cells from primed and boosted donors. As expected, no 
IgE antibodies were detected in control mice that had either received normal 
spleen cells or had not been secondarily challenged. 
A similar experiment employing the same priming regimen was carried out 
in BALB/c mice. Once again, very good adoptive secondary IgE anti-DNP 
antibody responses were elicited in recipients of primed cells which were chal- 
lenged with DNP-ASC whereas control mice either not challenged or injected 
with normal rather than primed donor cells failed to manifest detectable IgE 
serum antibodies.  Comparable results were obtained when A/J donors were 
primed with a single dose of 1/zg DNP-KLH plus 10 mg alum 8 wk before cell 
transfer. Secondary challenge of recipients with DNP-KLH plus alum elicited 
very  good  DNP-specific  IgE  responses,  whereas  again  appropriate  control 
groups made no detectable IgE antibody. 
The IgG antibody responses obtained in all of the adoptive transfer experi- 
ments were quite high in magnitude after challenge with the homologous antigen. 
TABLE I 
Adoptive Transfer of DNP-Specific [gE Antibody Responses with DNP-Primed Spleen Cells 
Mouse strain 
Protocol  Serum anti-DNP 
antibody 
Spleen ceils  Secondary  IgE 
transferred  Immunization  challenge  (PCA)*  IgG~ 
(,"g/ml) 
A/J  DNP-ASC-primed  4 wk earlier  DNP-ASC  2,560  1,068.5 
DNP-ASC-primed  4 wk earlier  None  <5  0.1 
DNP-ASC-primed  8 wk and 4 wk earlier  DNP-ASC  320  5,521.8 
DNP-ASC-primed  8 wk and 4 wk earlier  None  <5  1.7 
Normal  None  DNP-ASC  < 5  0.1 
BALB/c  DNP-ASC-primed  8 wk and 4 wk earlier  DNP-ASC  2,560  3,741.9 
DNP-ASC-primed  8 wk and 4 wk earlier  None  <5  0.7 
Normal  None  DNP-ASC  <5  0.1 
A/J  DNP-KLH-primed  8 wk earlier  DNP-KLH  5,120  642.8 
DNP-KLH-primed  8 wk earlier  None  <5  0.1 
Normal  None  DNP-KLH  <5  0.1 
* The data are expressed as the reciprocal of the highest PCA titer elicited by pooled sera from five mice of 
each recipient group bled 7 days after secondary challenge. 
:~ The data are expressed as geometric mean anti-DNP antibody  levels of sera from individual mice in each 
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This is particularly noteworthy in view of the fact that cell donors were primed 
without the use of bacterial adjuvants. The obviously high degree of priming 
obtained clearly reflects the immunogenic strength of the protein carriers, i.e. 
ASC and KLH, employed. It was also of interest that a clear dissociation oc- 
curred  between magnitude of  the  IgE  and IgG  antibody responses,  respec- 
tively, in the A/J recipients of spleen cells from donors that had been primed 
and boosted with DNP-ASC. Thus, whereas the IgG anti-DNP response was 
considerably higher than that obtained in recipients of singularly-primed donor 
cells, the IgE antibody response  was conversely much lower. 
The present studies have demonstrated the successful  adoptive transfer of 
hapten-specific secondary responses of the IgE antibody class.  Several points 
are noteworthy about this system: One less important point, but nevertheless 
somewhat surprising, was the relative ease with which adoptive secondary IgE 
responses could be obtained with transferred spleen cells. The successful  trans- 
fer of IgE responses with primed spleen cells not only makes this system some- 
what more practical for further studies, but also demonstrates clearly that all 
of the relevant participatory cells reside in the same organ environment known 
to contain the cells essential for development of responses  of the IgG antibody 
class. 
A second point concerns the magnitude of the IgE responses obtained after 
adoptive cell  transfer. The PCA titers,  in most instances, were considerably 
higher in  the  irradiated recipients  of primed  cells  after secondary challenge 
than those observed in secondary responses of intact animals. There are prob- 
ably two factors contributing to this observation: (a) the nonspecific prolifera- 
tive stimulus existing in the environment of an irradiated recipient; and (b) the 
absence of the predominant target tissue cell, i.e.,  the mast cell, to which IgE 
molecules would normally attach. This latter explanation derives from the fact 
that mast cells are relatively radiation-sensitive (14) and, therefore, would be 
deficient in an irradiated recipient. 
Finally, the  adoptive  transfer IgE  response  is  remarkably  similar  to  the 
adoptive transfer IgG antibody system in several respects. Thus, the optimal 
source of lymphocytes, the kinetics of anamnestic antibody production and, in 
general, the mode of donor priming are essentially identical for both types of 
antibody class  responses. One exception to the latter was the dissociation of 
IgE and IgG adoptive secondary responses obtained with DNP-ASC-primed 
cells from primed and boosted A/J donor mice. This did not occur, however, 
with similarly primed cells in BALB/c mice. Most importantly, the requirement 
for carrier-specificity in the elicitation of anti-DNP secondary IgE responses is 
rigidly maintained. Thus, by analogy with in vivo IgG antibody responses in 
hapten-carrier systems, the participation of carrier-specific  helper lymphocytes 
is clearly implied. This notion is consistent with the observations of Tada and 
Okumura in the rat (3), and of Kishimoto and Ishizaka in studies of in vitro 
IgE  antibody production  by  rabbit  lymph node  lymphocytes  (5).  Further 
studies to delineate the nature of carrier-specific  lymphocytes and  the com- 
parative  features  of their  capacity to  regulate  responses  of DNP-specific  B HAMAOY,  L~  ET  AL.  BRIEF  DEFINITIVE  REPORT  311 
lymphocytes of  the  IgE  and  IgG  antibody  class,  respectively, are currently 
underway. 
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